You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lxh254

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

NSCLC, Melanoma Trial in Worldwide (LXH254, LTT462, Trametinib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Melanoma
  • LXH254
  • +3 more
  • San Diego, California
  • +31 more
Sep 12, 2022

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

BRAF V600 Colorectal Cancer Trial in Worldwide (Dabrafenib, LTT462, Trametinib)

Recruiting
  • BRAF V600 Colorectal Cancer
  • Los Angeles, California
  • +17 more
Jun 7, 2022